Literature DB >> 6158579

Purification and biochemical characterization of the Epstein-Barr virus-determined nuclear antigen and an associated protein with a 53,000-dalton subunit.

J Luka, H Jörnvall, G Klein.   

Abstract

The Epstein-Barr virus-determined nuclear antigen (EBNA) was purified 700-fold to apparent homogeneity from Raji and Namalwa cell extracts by a three-step procedure involving heat treatment, DNA-cellulose chromatography, and hydroxyapatite chromatography. Acid-fixed nuclear binding and complement fixation were used to monitor antigenic specificity. Purified EBNA was also capable of specifically inhibiting the regular anticomplement immunofluorescence reaction for EBNA against Raji target cells. The purified antigen had a molecular weight of 170,000 to 200,000. By sodium dodecyl sulfate-polyacrylamide gel electrophoresis, it yielded a single 48,000-dalton (48K) monomer. An EBNA-associated protein was also purified from the same cell extract. It had a molecular weight of about 200,000 and yielded a single 53K protein band by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The same protein was also found in Epstein-Barr virus negative B-cell lymphoma lines. The two types of protein were characterized by amino acid composition and peptide mapping. The results showed that the 53K and 48K protein components have no long regions in common; this excludes that the smaller product arises by breakdown of the larger product. Residue distributions were different, but an excess of hydrophilic residues was found in both proteins, suggesting a certain overall similarity in properties. 53K components from different cell lines appeared to differ somewhat. Epstein-Barr virus-positive lines carry two 53K components, one of which may be a slightly modified 53K product. Immunocomplexing assay showed that the 48K, but not the 53K, protein carries EBNA specificity. In mixtures, the 53K protein is co-precipitated with the 48K protein. The data suggest that EBNA may form a complex with the 53K proten within the cell.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6158579      PMCID: PMC288853          DOI: 10.1128/JVI.35.3.592-602.1980

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  An improved large scale fractionation of high mobility group non-histone chromatin proteins.

Authors:  G H Goodwin; R H Nicolas; E W Johns
Journal:  Biochim Biophys Acta       Date:  1975-10-20

2.  Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.

Authors:  J Minowada; T Onuma; G E Moore
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

3.  Malignant immunoblastoma: immunoglobulin synthesis and the progression to leukemia in heterotransplanted acute lymphoblastic leukemia, chronic lymphatic leukemia, lymphoma, and infectious mononucleosis.

Authors:  R A Adams; L Pothier; E E Hellerstein; G Boileau
Journal:  Cancer       Date:  1973-06       Impact factor: 6.860

4.  Relationship between the sensitivity of EBV-carrying lymphoblastoid lines to superinfection and the inducibility of the resident viral genome.

Authors:  G Klein; L Dombos
Journal:  Int J Cancer       Date:  1973-03-15       Impact factor: 7.396

5.  Relationship between Epstein-Barr virus-determined complement-fixing antigen and nuclear antigen detected by anticomplement fluorescence.

Authors:  G Klein; V Vonka
Journal:  J Natl Cancer Inst       Date:  1974-12       Impact factor: 13.506

6.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

7.  Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji).

Authors:  M A Epstein; B G Achong; Y M Barr; B Zajac; G Henle; W Henle
Journal:  J Natl Cancer Inst       Date:  1966-10       Impact factor: 13.506

8.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

9.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

10.  High resolution acrylamide gel electrophoresis of histones.

Authors:  S Panyim; R Chalkley
Journal:  Arch Biochem Biophys       Date:  1969-03       Impact factor: 4.013

View more
  26 in total

1.  Epstein-Barr virus/complement fragment C3d receptor (CR2) reacts with p53, a cellular antioncogene-encoded membrane phosphoprotein: detection by polyclonal anti-idiotypic anti-CR2 antibodies.

Authors:  M Barel; A Fiandino; F Lyamani; R Frade
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

2.  Epstein-Barr virus RNA. VI. Viral RNA in restringently and abortively infected Raji cells.

Authors:  W King; V Van Santen; E Kieff
Journal:  J Virol       Date:  1981-05       Impact factor: 5.103

3.  Cloning and expression analysis of full length mouse cDNA sequences encoding the transformation associated protein p53.

Authors:  J R Jenkins; K Rudge; S Redmond; A Wade-Evans
Journal:  Nucleic Acids Res       Date:  1984-07-25       Impact factor: 16.971

4.  Antibodies of predetermined specificity for the NH2 terminus of a cellular protein p53 react with the native molecule: evidence for the presence of different p53s.

Authors:  J Luka; L Sternås; H Jörnvall; G Klein; R Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

5.  Microinjection of monoclonal antibody to protein p53 inhibits serum-induced DNA synthesis in 3T3 cells.

Authors:  W E Mercer; D Nelson; A B DeLeo; L J Old; R Baserga
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

6.  Regulation of the cellular p53 tumor antigen in teratocarcinoma cells and their differentiated progeny.

Authors:  M Oren; N C Reich; A J Levine
Journal:  Mol Cell Biol       Date:  1982-04       Impact factor: 4.272

7.  Pancreatic adenocarcinomas frequently show p53 gene mutations.

Authors:  A Scarpa; P Capelli; K Mukai; G Zamboni; T Oda; C Iacono; S Hirohashi
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

8.  Epstein-Barr virus RNA VII: size and direction of transcription of virus-specified cytoplasmic RNAs in a transformed cell line.

Authors:  V van Santen; A Cheung; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

9.  High levels of p53 protein expression do not correlate with p53 gene mutations in anaplastic large cell lymphoma.

Authors:  E Cesarman; G Inghirami; A Chadburn; D M Knowles
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

10.  Molecular cloning of a cDNA specific for the murine p53 cellular tumor antigen.

Authors:  M Oren; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.